Anti-inflammatory strategies and hemostatic agents: old drugs, new ideas.

Published

Other Article (Review)

Hemostatic abnormalities occur following injury associated with both cardiac and noncardiac surgery. These changes are part of inflammatory pathways with signaling mechanisms that link these diverse pathways. The inflammatory response to surgery is exacerbated by allogeneic blood transfusion by enhancing intrinsic inflammatory activity and directly increasing plasma levels of inflammatory mediators. Surgical patients can be preventively treated with pharmacologic agents to modulate inflammatory responses. Multiple studies have reported preventive pharmacologic therapies to reduce bleeding and the need for allogeneic transfusions in surgery. Strategies for cardiac surgical patients during cardiopulmonary bypass include administration of either lysine analogs, such as epsilon aminocaproic acid and tranexamic acid, or the serine protease inhibitor aprotinin.

Full Text

Duke Authors

Cited Authors

  • Levy, JH

Published Date

  • February 2007

Published In

Volume / Issue

  • 21 / 1

Start / End Page

  • 89 - 101

PubMed ID

  • 17258120

Pubmed Central ID

  • 17258120

International Standard Serial Number (ISSN)

  • 0889-8588

Digital Object Identifier (DOI)

  • 10.1016/j.hoc.2006.11.007

Language

  • eng

Conference Location

  • United States